SAB Biotherapeutics to trade on Nasdaq following merger
Sioux Falls-based SAB Biotherapeutics plans to merge with a Miami-based firm, which will allow it to trade on the Nasdaq.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
